Skip to main content
Clinical Trials/NCT04936711
NCT04936711
Unknown
Phase 4

Randomized Prospective Interventional Study: Pain Relief After Laparoscopic Primary Hiatal Hernia Repair

Norton Thoracic Institute1 site in 1 country90 target enrollmentMay 12, 2021

Overview

Phase
Phase 4
Intervention
Resteck Shiatsu Neck and Back Massager
Conditions
Shoulder Pain
Sponsor
Norton Thoracic Institute
Enrollment
90
Locations
1
Primary Endpoint
Opioid and Non-Opioid Usage Postoperative Period
Last Updated
4 years ago

Overview

Brief Summary

Referred shoulder pain (pain felt when the problem is actually in a different location) is very common after laparoscopic (small, narrow cut) hernia surgery. The purpose of this study is to look at the effect of a simple back massager, which can be readily purchased online or in a store, in addition to the use of standard pain medications.

Registry
clinicaltrials.gov
Start Date
May 12, 2021
End Date
November 30, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Norton Thoracic Institute
Responsible Party
Principal Investigator
Principal Investigator

Leslie Munson

Research Program Manager

Norton Thoracic Institute

Eligibility Criteria

Inclusion Criteria

  • Scheduled for primary hiatal hernia repair
  • Adult 18 years of age or older
  • Undergoing minimally invasive surgical technique

Exclusion Criteria

  • Recurrent hiatal hernia
  • Children under the age of 18 years
  • Undergoing open or hybrid surgical technique
  • History of psychiatric disorder or chronic pain
  • Has a post-operative complication (Grade \> I on Calvien Dindo classification)
  • Allergy to standard pain medication regimen (local anesthetics Marcaine, lidocaine, and epinephrine; morphine; oxycodone; Tylenol)

Arms & Interventions

Back Massager Device + Standard Pain Treatment

Resteck Shiatsu Neck and Back Massager (brand name), with recommended use for at least every 2 hours for at least 15 minutes on the first post-operative day and then every 4 hours for 2 days and then as needed. Standard pain treatment: 1. Local anesthetic agent at the incision sites include: 0.5% Marcaine (10 cc) + 0.5% lidocaine and epinephrine (10 cc) (total volume: 20 cc) 2. Morphine 2 mg: Intravenous administration every 2 hours or as needed, if unable to take pills by mouth 3. Oxycodone 5 - 10 mg elixir: oral administration every 6 hours or as needed 4. Tylenol 650 mg Tab: oral administration every 6 hours

Intervention: Resteck Shiatsu Neck and Back Massager

Marcaine spray + Standard Pain Treatment

30cc of 0.25% Marcaine spray on the diaphragm at the end of surgery. Standard pain treatment: 1. Local anesthetic agent at the incision sites include: 0.5% Marcaine (10 cc) + 0.5% lidocaine and epinephrine (10 cc) (total volume: 20 cc) 2. Morphine 2 mg: Intravenous administration every 2 hours or as needed, if unable to take pills by mouth 3. Oxycodone 5 - 10 mg elixir: oral administration every 6 hours or as needed 4. Tylenol 650 mg Tab: oral administration every 6 hours

Intervention: Marcaine

Outcomes

Primary Outcomes

Opioid and Non-Opioid Usage Postoperative Period

Time Frame: 2 years

Subject diary to list any medications taken for pain relief after surgery, and will list the following: name of medication, dose of medication, date and time medication taken

Visual Analogue Score Pain Questionnaire

Time Frame: 2 years

Pain score questionnaire to rate pain on a scale of 0 - 10, with 0 being no pain and 10 being the worst possible pain imaginable. The higher the score, the worse the outcome.

Study Sites (1)

Loading locations...

Similar Trials